All In Biotech

Drug Trial Radar · NCT04646603

MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients

A Phase IIa, Adaptive, Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study in Hospitalized Patients Infected With Severe and Critical SARS-CoV-2 to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of MRG-001

Last checked: Nov 20, 2026Latest source record: Feb 15, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

40

Planned (sponsor's estimate)

Start

Dec 1, 2021

Primary completion

Mar 31, 2022

Study completion Jul 1, 2022

Sponsor

Lead sponsor
MedRegen LLCIndustry
Sponsor type
Industry
Collaborators
ICON plc; Johns Hopkins University
First posted
Nov 30, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study consists of two parts. Part A (Phase I): A Phase I Double-blind Randomized Placebo-controlled Study in Healthy Subjects to Assess the Safety, Pharmacokinetics, Pharmacodynamics of MRG-001 Part B (Phase 2): A Phase IIa, Adaptive, Double-Blind, Randomized, Placebo-controlled, Multi-center Study in Hospitalized Patients Infected with Severe and Critical SARS-CoV-2 to Assess the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of MRG-001

Conditions

  • COVID-19
  • ARDS, Human
  • Stem Cells
  • Regeneration

Interventions

  • MRG-001Drug

    Subjects will receive subcutaneous MRG-001 injections.

  • PlaceboDrug

    Subjects will receive subcutaneous placebo injections.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and TolerabilityTime frame: 60 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Johns Hopkins Medicine

    Baltimore, Maryland · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.